Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Pruritus Therapeutics Market Growth Potential: How Will Market Size Shift Through 2030?
The pruritus therapeutics market has shown robust expansion in recent years. Its valuation is expected to rise from $12.38 billion in 2025 to $13.08 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.6%. This prior growth can be linked to factors such as the increasing incidence of inflammatory skin conditions, the heightened application of corticosteroids and antihistamines, an uplift in dermatology research investment, the widening reach of hospital and clinic networks, and the prompt adoption of topical treatments.
The pruritus therapeutics market is projected to experience robust expansion over the coming years, forecast to reach a valuation of $16.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This anticipated growth can be attributed to several factors, including advancements in genomics and precision medicine, the emergence of new immunosuppressants, the increasing adoption of digital health and remote dermatology solutions, the expanding market for over-the-counter (OTC) pruritus products, and a heightened emphasis on managing chronic skin diseases. Key trends anticipated during this period involve personalized treatment strategies for pruritus, a stronger emphasis on anti-inflammatory therapies, the development and increased use of topical formulations and delivery systems, further expansion of over-the-counter (OTC) pruritus products, and a growing public awareness of chronic skin conditions.
Get A Free Sample Report With In-Depth Market Insights:
Pruritus Therapeutics Market Growth Drivers: What’s Behind The Acceleration?
An increasing occurrence of dermatological disorders is projected to stimulate the expansion of the pruritus therapeutics market in the future. These conditions encompass ailments affecting the skin, hair, nails, and mucous membranes, ranging from common issues like acne and eczema to more serious ones such as skin cancer and fungal infections. The specific reason for itching frequently dictates which pruritus treatments are employed for skin-related illnesses. Management of this condition involves various approaches, including topical applications, emollients and moisturizers, immunosuppressant drugs, and anti-itch medications. As an illustration, the American Cancer Society, a US-based non-profit organization focused on cancer eradication, reported in January 2024 that skin cancer cases are anticipated to reach 108,270, marking a 3.2% rise from the 104,930 cases documented in 2023. Consequently, the growing prevalence of dermatological disorders is fueling the expansion of the pruritus therapeutics market.
Pruritus Therapeutics Market Segment Analysis Spotlighting Growth Areas
The pruritus therapeutics market covered in this report is segmented –
1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies
Pruritus Therapeutics Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the pruritus therapeutics market are concentrating on developing innovative biologic treatments, such as monoclonal antibody therapy, to effectively target and relieve the itching linked to conditions like atopic dermatitis and prurigo nodularis. Monoclonal antibody treatment involves using laboratory-produced molecules specifically engineered to target certain proteins in the body, which are typically involved in disease mechanisms. For instance, in June 2024, Maruho Co., Ltd., a Japan-based pharmaceutical company, introduced Mitchga Subcutaneous Injection (30mg vials) in Japan. This product is designed for treating pruritus associated with atopic dermatitis in children (ages 6-13) and prurigo nodularis in adults and adolescents (ages =13) when other treatments have proven ineffective. The product contains nemolizumab, a humanized monoclonal antibody that targets the interleukin-31 (IL-31) receptor. By inhibiting IL-31, the drug aims to alleviate itching and improve the quality of life for patients suffering from these conditions.
Pruritus Therapeutics Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the pruritus therapeutics market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Trevi Therapeutics Inc., AbbVie Biopharmaceuticals, Amgen Inc., Allergan plc, Horizon Therapeutics plc, Kyowa Kirin Co. Ltd., Dermira Inc., Pfizer Consumer Healthcare
View The Full Pruritus Therapeutics Market Report:
Pruritus Therapeutics Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the pruritus treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model